← Comparing 2 hypotheses side-by-side
Add hypothesis:
— Select a hypothesis to add —
Closed-loop focused ultrasound targeting EC-II SST interneur (SST) — 1.00 Closed-loop transcranial focused ultrasound with 40Hz gamma (PVALB) — 1.00 Metabolic Reprogramming to Reverse Senescence (SIRT1,PGC1A,NAMPT) — 1.00 Closed-loop transcranial focused ultrasound to restore hippo (PVALB) — 1.00 Closed-loop tACS targeting EC-II SST interneurons to block t (SST) — 1.00 Closed-loop tACS targeting EC-II PV interneurons to suppress (PVALB) — 0.99 Beta-frequency entrainment therapy targeting PV interneuron- (SST) — 0.99 TREM2-Dependent Astrocyte-Microglia Cross-talk in Neurodegen (TREM2) — 0.99 Hippocampal CA3-CA1 synaptic rescue via DHHC2-mediated PSD95 (BDNF) — 0.99 Closed-loop tACS targeting EC-II parvalbumin interneurons to (PVALB) — 0.98 SASP Modulation Rather Than Cell Elimination (NFKB1,IL1B,BDNF) — 0.98 LRP1-Dependent Tau Uptake Disruption (LRP1) — 0.98 Hypothesis 7: SST-SST1R/Gamma Entrainment-Enhanced Astrocyte (SST, SSTR1, SSTR2) — 0.97 TREM2-Dependent Microglial Senescence Transition (TREM2) — 0.95 Closed-loop transcranial focused ultrasound targeting EC-II (SST) — 0.95 Closed-loop optogenetic targeting PV interneurons to restore (PVALB) — 0.94 PLCG2 Allosteric Modulation as a Precision Therapeutic for T (PLCG2) — 0.94 Plasma p-tau217-Triggered Exosome Dosing Maximizes lncRNA-00 (CSF p-tau217 (biomarker), lncRNA-0021, hUC-MSC exosomes) — 0.94 Dual-Receptor Antibody Shuttling (%s) — 0.94 SASP-Driven Microglial Metabolic Reprogramming in Synaptic P (HK2/PFKFB3) — 0.93 Multi-Biomarker Composite Index Surpassing Amyloid PET for T (COMPOSITE_BIOMARKER) — 0.93 Closed-loop transcranial alternating current stimulation to (SST) — 0.93 Closed-loop focused ultrasound targeting CA1 PV interneurons (PVALB) — 0.93 Closed-loop transcranial focused ultrasound targeting EC-II (SST) — 0.92 Autophagy-Senescence Axis Therapeutic Window (ATG7,BCL2,BCL2L1) — 0.92 HK2-Dependent Metabolic Checkpoint as the Gatekeeper of DAM (HK2) — 0.92 Palmitoylethanolamide-Based Endocannabinoid Therapy (PPARA) — 0.92 Closed-loop tACS targeting entorhinal cortex layer II SST in (SST) — 0.92 TREM2-mediated microglial tau clearance enhancement (TREM2) — 0.92 Chromatin Remodeling-Mediated Nutrient Sensing Restoration (SMARCA4) — 0.91
Add
|
× Metabolic Accumulation (A × IL-6 Trans-Signaling Bloc
NRF2/NFE2L2 · neuroinflammation · -
Composite 0.517
Price $0.52
Evidence For 0
Evidence Against 0
Hyperammonemia and manganese accumulation in cirrhotic brains activate NRF2-mediated antioxidant response, which cross-suppresses pro-inflammatory genes including AIF1/IBA1 as part of a global transcriptional reprogramming. This hypothesis has the weakest mechanistic chain: NRF2-ARE signaling typically upregulates protective genes, and no mechanism for NRF2-mediated repression of homeostatic microglial genes is established.
IL6R, IL6 · neuroinflammation · mechanistic
Composite 0.806
Price $0.74
Evidence For 0
Evidence Against 0
In the established paradigm, microglia are primary drivers of neuroinflammation. However, oligodendrocyte-derived IL-6 may prime microglia through IL-6 trans-signaling (IL-6/sIL-6R/gp130), creating a self-reinforcing inflammatory loop. Blocking soluble IL-6 receptor (sIL-6R) specifically at the oligodendrocyte-microglia interface would interrupt this amplification circuit without globally suppressing IL-6, preserving its neuroprotective functions. This extends the SASP-complement cascade concept
Verdict Summary 1/10
dimensions won
Metabolic Accumulation (Ammonia/Manganes
9/10
dimensions won
IL-6 Trans-Signaling Blockade at the Oli
Radar Chart — 10 Dimensions
Score Breakdown
Dimension Metabolic Accumulation (Ammoni IL-6 Trans-Signaling Blockade Mechanistic 0.400 0.820 Evidence 0.480 0.780 Novelty 0.580 0.650 Feasibility 0.450 0.720 Impact 0.550 0.800 Druggability 0.550 0.850 Safety 0.600 0.580 Competition 0.650 0.750 Data 0.550 0.820 Reproducible 0.500 0.780
Evidence Metabolic Accumulation (Ammonia/Manganese) Triggers IBA1 Dow No evidence citations yet
IL-6 Trans-Signaling Blockade at the Oligodendrocyte-Microgl No evidence citations yet
Debate Excerpts Metabolic Accumulation (Ammonia/Manganese) Trigger 4 rounds · quality: 0.76
Theorist # Therapeutic and Mechanistic Hypotheses: IBA1 Low/Negative Microglia in Liver Disease
## Hypothesis 1: Liver-Derived Inflammatory Suppressors Downregulate Microglial IBA1
**Mechanism:** Soluble liv...
Skeptic # Critical Evaluation of IBA1 Low/Negative Microglia Hypotheses
I'll systematically evaluate each hypothesis against your skeptic's framework, identifying mechanistic weaknesses, missing controls, al...
Domain Expert # Feasibility Assessment: IBA1 Low/Negative Microglia in Liver Disease
## Prefatory Notes on Surviving Hypotheses
From the skeptic's prior evaluation (partial), the surviving candidates with suffici...
Synthesizer {"ranked_hypotheses":[{"title":"Peripheral Monocyte/Macrophage Infiltration Mimicking Microglial Loss","description":"Liver disease compromises BBB integrity via MMP-9 upregulation, enabling CCR2+ per...
IL-6 Trans-Signaling Blockade at the Oligodendrocy 4 rounds · quality: 0.79
Theorist
# Mechanistic Hypotheses: Oligodendrocyte-Driven Neuroinflammation in PD
---
## Hypothesis 1: PSAP Cleavage Pattern Determines Pro-inflammatory vs. Protective Function
**Title:** Altered Prosapos...
Skeptic
# Critical Evaluation: Hypothesis 1 — PSAP Cleavage Pattern
## Summary of Hypothesis
Dysregulated PSAP cleavage (via elevated cathepsins/MMPs) generates pathogenic saposin fragments that over-activ...
Domain Expert
# Domain Expert Response: PD Translational Assessment
## Preliminary Note: AD vs. PD Context
I notice the query references an "Alzheimer's clinical landscape," but the research question, source pa...
Synthesizer
{
"ranked_hypotheses": [
{
"rank": 1,
"title": "Altered PSAP Cleavage Generates Pro-inflammatory Fragments in Oligodendrocytes",
"mechanism": "Disease-associated proteases (c...
Price History Overlay
Knowledge Graph Comparison
Metabolic Accumulation (Ammonia/Manganes
0 edges
Top Node Types
Top Relations
IL-6 Trans-Signaling Blockade at the Oli
2 edges
Top Relations promoted: IL-6 Trans-Signaling Blockade at the Oligodendrocyte-Microglia Interface 1
promoted: PDE4 Inhibition as Inflammatory Reset for PD Oligodendrocytes 1